• Multi-Omics Mapping of ARID1A-Dependent Resistance in Melano

  2026-07-08

  This study leverages integrative multi-omics to delineate early resistance mechanisms to BRAF/MAPK inhibition in melanoma, focusing on the role of ARID1A loss. The findings identify key adaptive signaling nodes—PRKD1, JUN, and NCK1—that may inform future strategies to overcome resistance and enhance research models.

• Dihydroethidium (DHE) in Redox Biology: Advancing Superoxide

  2026-07-08

  Explore the unique role of dihydroethidium in superoxide detection and oxidative stress assays. This article integrates advanced mechanistic insights and new research findings to empower apoptosis and cardiovascular disease research.

• SCH772984 HCl: Potent ERK1/2 Inhibitor for MAPK Pathway Rese

  2026-07-07

  SCH772984 HCl is a highly potent and selective ERK1/2 inhibitor used to dissect MAPK signaling and overcome resistance in BRAF- and RAS-mutant cancers. It exhibits nanomolar inhibition, robust antiproliferative activity in vitro and in vivo, and is a critical tool for mechanistic studies. This article details its mechanism, benchmarks, and practical workflow integration.

• Necrosulfonamide: Optimizing Necroptosis Assays in Translati

  2026-07-07

  Necrosulfonamide (NSA) delivers precise, MLKL-targeted inhibition for dissecting necroptotic cell death, enabling high-fidelity necroptosis assays in cancer and cardiovascular disease models. This article translates cutting-edge reference findings into practical, stepwise workflows and troubleshooting guidance, empowering researchers to maximize NSA’s impact in advanced cell death pathway research.

• Phosbind Acrylamide: Redefining Phosphate-Binding in Plant M

  2026-07-06

  Discover how Phosbind Acrylamide transforms phosphate-binding reagent workflows in protein phosphorylation analysis, with a unique focus on plant MAPK signaling and experimental design. Gain nuanced insights for advanced SDS-PAGE phosphorylation detection.

• Transcranial K+-Channelrhodopsin Inhibition Suppresses Seizu

  2026-07-06

  This study introduces a highly sensitive, K+-selective channelrhodopsin (HcKCR1-hs) engineered for transcranial optogenetic inhibition of neural hyperactivity. The noninvasive approach significantly reduced seizure activity in mouse models, opening new avenues for treating neurological disorders like epilepsy.

• WM-8014: Precision KAT6A Inhibitor for Cancer Biology Resear

  2026-07-05

  WM-8014 stands out as a selective, reversible KAT6A inhibitor, enabling precise oncogene-induced senescence assays and cell cycle arrest studies with minimal cytotoxicity. Its competitive acetyl-CoA site inhibition and robust selectivity profile empower advanced epigenetic research workflows—especially where pathway specificity and reproducibility are paramount.

• AIBP-LRP2–HDL Axis Regulates CXCR4+ Capillary Expansion in I

  2026-07-04

  Zhu et al. reveal that AIBP-LRP2–mediated HDL uptake limits the expansion of stem-like CXCR4+ capillary endothelial cells (CECs), constraining collateral circulation in ischemic disease. The study elucidates a two-phase mechanism underlying vascular remodeling and identifies a novel regulatory axis with therapeutic implications for peripheral artery disease.

• Affinity-Purified Goat Anti-Mouse IgG (H+L) HRP Conjugated:

  2026-07-03

  Unlock high-sensitivity immunodetection using the Affinity-Purified Goat Anti-Mouse IgG (H+L), HRP Conjugated secondary antibody. This guide delivers practical protocol enhancements and troubleshooting insights for Western blot, ELISA, and IHC, building on the latest literature and experimental breakthroughs.

• Directed Evolution of GPCRs: DREADDs and Clozapine N-oxide I

  2026-07-03

  The reference study pioneered the engineering of muscarinic GPCRs, enabling their selective activation by the inert ligand clozapine N-oxide (CNO). This approach established chemogenetic DREADD technology, providing a precise tool for dissecting signal transduction pathways and modulating neuronal activity in vitro and in vivo.

• Z-VDVAD-FMK: Applied Caspase-2 Inhibition for Apoptosis Assa

  2026-07-02

  Z-VDVAD-FMK empowers researchers to dissect caspase-2-mediated apoptosis and mitochondrial pathways with high specificity and reproducible performance. Its robust solubility and workflow compatibility, validated across diverse cell models, position it as a premium tool for mechanistic studies and translational cancer research.

• VGluT2 PVT Neuron Modulation in Paraquat-Induced PD Depressi

  2026-07-02

  This study identifies VGluT2 glutamatergic neuron subtypes in the paraventricular thalamic nucleus (PVT) as key modulators of depression in paraquat-induced Parkinson’s disease (PD) models. The work advances understanding of neural circuitry underlying PD-associated depression, highlighting new experimental approaches for circuit-specific neuronal activity modulation.

• PD0325901: MEK Inhibitor-Driven Precision in Cancer Research

  2026-07-01

  PD0325901 stands out as a potent, selective MEK inhibitor, enabling researchers to dissect oncogenic RAS/RAF/MEK/ERK signaling and precisely modulate cell fate in cancer models. This guide details actionable workflows, advanced troubleshooting, and how recent discoveries in TERT regulation can be leveraged for next-generation experimental design.

• JC-1: Advancing Translational Mitochondrial Research

  2026-07-01

  Explore how JC-1, a cationic fluorescent dye, is revolutionizing mitochondrial membrane potential assays and apoptosis detection in translational research. This article offers mechanistic insight, strategic guidance, and practical protocols for integrating JC-1 into advanced bioenergetics studies, while highlighting APExBIO’s leadership in assay quality and reliability.

• FXR Protein Phase Separation Drives β-Coronavirus Replicatio

  2026-06-30

  Li et al. (2024) demonstrate that fragile X–related (FXR) proteins, via liquid–liquid phase separation (LLPS), organize the clustering of replication organelles needed for efficient β-coronavirus proliferation. This discovery reveals a crucial host-driven mechanism in viral replication, providing new insights for antiviral research and the study of membraneless cellular organization.

16989 records 1/1133 page Next 12345 下5页 Last page